1. Home
  2. CSAN vs MMSI Comparison

CSAN vs MMSI Comparison

Compare CSAN & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cosan S.A. ADS

CSAN

Cosan S.A. ADS

HOLD

Current Price

$4.96

Market Cap

4.3B

ML Signal

HOLD

MMSI

Merit Medical Systems Inc.

HOLD

Current Price

$77.31

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSAN
MMSI
Founded
1936
1987
Country
Brazil
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.9B
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
CSAN
MMSI
Price
$4.96
$77.31
Analyst Decision
Hold
Strong Buy
Analyst Count
2
9
Target Price
$4.75
$103.56
AVG Volume (30 Days)
1.9M
603.0K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
4.93
EPS
N/A
2.13
Revenue
N/A
$1,515,906,000.00
Revenue This Year
$270.73
$7.99
Revenue Next Year
$2.12
$5.62
P/E Ratio
N/A
$36.62
Revenue Growth
N/A
11.75
52 Week Low
$3.72
$76.68
52 Week High
$6.25
$107.27

Technical Indicators

Market Signals
Indicator
CSAN
MMSI
Relative Strength Index (RSI) 55.26 37.02
Support Level $4.36 N/A
Resistance Level $5.23 $85.09
Average True Range (ATR) 0.24 2.49
MACD 0.02 -0.23
Stochastic Oscillator 49.73 8.56

Price Performance

Historical Comparison
CSAN
MMSI

About CSAN Cosan S.A. ADS

Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Share on Social Networks: